Clinical Glomerulonephritis 1

7 Feb 2025 5:30 p.m. 6:30 p.m.

Piyali Sarkar Moderator

Time	Session

12 a.m. 12 a.m.	A CASE REPORT OF SERONEGATIVE LUPUS NEPHRITIS WCN25-AB-3100, Poster Board= FRI-154	MALE LUPUS NEPHRITIS: A COMPREHENSIVE ANALYSIS OF CLINICAL FEATURES, SEROLOGICAL MARKERS, AND TREATMENT OUTCOMES WCN25-AB-4210, Poster Board= FRI-155	POTENTIAL DIAGNOSTIC ROLE OF URINARY EXOSOMAL MIRNAS IN IGA NEPHROPATHY: A CLINICAL OBSERVATIONAL STUDY WCN25-AB-2338, Poster Board= FRI-156	PODOCYTE INFOLDING GLOMERULOPATHY IN A SCHOOL-AGED INDIAN CHILD: A NOVEL CASE REPORT WCN25-AB-1177, Poster Board= FRI-157	DYSMORPHIC VS ISOMORPHIC MICROHEMATURIA IN THE DIAGNOSTIC APPROACH OF GLOMERULAR DISEASES WCN25-AB-1052, Poster Board= FRI-158	SALIVARY AND URINARY METABOLOMICS STUDY IN IGA NEPHROPATHY PATIENTS WCN25-AB-1709, Poster Board= FRI-159	FLARES, INFECTIONS AND PREDICTORS OF MAJOR ADVERSE KIDNEY EVENTS IN INDIAN CHILDREN WITH LUPUS NEPHRITIS: A COHORT STUDY WCN25-AB-3440, Poster Board= FRI-160	ORIGIN EXTEND: A LONG-TERM EXTENSION STUDY OF ATACICEPT IN IGAN WCN25-AB-2522, Poster Board= FRI-162	ALIGN SUBGROUP ANALYSES: CLINICALLY MEANINGFUL UPCR REDUCTIONS SEEN ACROSS SUBGROUPS WCN25-AB-1638, Poster Board= FRI-163	AFFINITY STUDY: 1-YEAR RESULTS OF ATRASENTAN IN IGA NEPHROPATHY (IGAN) WCN25-AB-778, Poster Board= FRI-164	DETERMINATION OF NEUTROPHIL TO ALBUMIN RATIO, NEUTROPHIL TO C3 COMPLEMENT RATIO AND ALBUMIN TO GLOBULIN RATIO IN THE ASSESSMENT OF LUPUS NEPHRITIS ACTIVITY WCN25-AB-267, Poster Board= FRI-165	OBSERVATIONAL ANALYSIS OF TREATMENT OUTCOMES AND ASSOCIATION OF PLA2R LEVELS IN PRIMARY MEMBRANOUS NEPHROPATHY IN A TERTIARY CARE CENTER OF EASTERN INDIA WCN25-AB-3960, Poster Board= FRI-166	SPARSENTAN (SPAR) AS FIRST-LINE TREATMENT OF INCIDENT PATIENTS WITH IGA NEPHROPATHY (IGAN): INTERIM ANALYSIS OF THE SPARTAN TRIAL WCN25-AB-1884, Poster Board= FRI-167	FLARES, INFECTIONS AND PREDICTORS OF MAJOR ADVERSE KIDNEY EVENTS IN INDIAN CHILDREN WITH LUPUS NEPHRITIS: A COHORT STUDY WCN25-AB-3440, Poster Board= FRI-160	FLARES, INFECTIONS AND PREDICTORS OF MAJOR ADVERSE KIDNEY EVENTS IN INDIAN CHILDREN WITH LUPUS NEPHRITIS: A COHORT STUDY WCN25-AB-745, Poster Board= FRI-161	EFFICACY OF INDUCTION TREATMENT WITH CYCLOPHOSPHAMIDE, RITUXIMAB AND THEIR COMBINATION IN PATIENTS WITH PAUCIIMMUNE VASCULITIS WCN25-AB-2290, Poster Board= FRI-168	PERCUTANEOUS RENAL BIOPSY IN SMALL KIDNEYS: A USEFUL AND SAFE PROCEDURE WCN25-AB-1475, Poster Board= FRI-169	IMPLICATIONS OF PROTEINURIA REMISSION ON ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) TRAJECTORY IN PATIENTS (PTS) WITH IGA NEPHROPATHY (IGAN) IN PROTECT WCN25-AB-1898, Poster Board= FRI-170	CLINICO-HISTOPATHOLOGICAL PROFILE OF PATIENTS UNDERGOING RENAL BIOPSY AT AIIMS PATNA- ONE YEAR REGISTRY WCN25-AB-345, Poster Board= FRI-171	ACUTE KIDNEY INJURY IN IGA NEPHROPATHY WITH CHRONIC LIVER DISEASE: RENAL OUTCOMES AND THERAPEUTIC IMPACT FROM A PROSPECTIVE STUDY WCN25-AB-4501, Poster Board= FRI-172	CLINICOPATHOLOGICAL CHARACTERISTICS OF LUPUS NEPHRITIS AT A TERTIARY CARE CENTER IN NIGERIA WCN25-AB-189, Poster Board= FRI-173	LONG-TERM RESULTS FROM THE ORIGIN PHASE 2B STUDY OF ATACICEPT FOR THE TREATMENT OF IGAN WCN25-AB-2470, Poster Board= FRI-174